The following is a summary of “Causal relationship between major depressive disorder, anxiety disorder and constipation: a ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

Researchers develop machine learning tools that screen for co-morbid anxiety disorders and major depressive disorder using acoustic voice signals. The team spoke to participants with and without ...

Harvard researchers have found that M. morganii may contribute to depression by producing an inflammatory molecule.

Speaking in depth about her depression, Welch shared the tell-tale signs that occur in her body when a depressive episode is ...

It's no secret that there is a mental health crisis in the United States. As of 2021, 8.3% of adults had major depressive ...

The following is a summary of “Risks of adverse events with mirtazapine for adults with major depressive disorder: a ...

Mendelian randomization analysis of genome-wide association study data suggests schizophrenia and major depressive disorder may cause constipation. Constipation, a common and often debilitating ...

Axsome Therapeutics (AXSM) is climbing nearly 4% after Swiss bank UBS increased its price target on the shares to $133 from ...

In 2019 an international team of researchers identified 109 genes that were associated in different combinations with eight different psychiatric disorders, including autism, ADHD, schizophrenia, ...

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want ...